Celgene Corporation Stock Price and Value Analysis

Should you buy Celgene Corporation stock? (NasdaqGS:CELG). Let's see how it does in our automated value investing analysis system.

  • This company is very stable.
  • This company has stable growth.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the CELG Numbers

CELG Price
(Celgene Corporation stock price per share)
[?] CELG Fair Price
(based on intrinsic value)
[?] CELG Safety Price (based on a variable margin of safety) $23.50
[?] PE Ratio versus Sector 15% higher than other Healthcare stocks
[?] PE Ratio versus Industry 59% lower than other Biotechnology stocks
[?] Cash Yield 6.06%
[?] Free Cash Flow Jitter 18%

Is Celgene Corporation Stock on Sale?

We believe that Celgene Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Celgene Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CELG Stock?

Does Celgene Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.